Post-Operative Mask Protocol in US Plastic Surgery Clinics vs Canada: Which Rules Apply?
The patient is face-down under a drape, the procedure is finished, and the room has six minutes before the next booking. In that gap two masks matter: the one on the clinician's face and the one going onto the patient's skin. Most clinics have a rule for each. Fewer have written those rules down as one protocol, and fewer still know that the two halves are governed by completely different regulators.
This is the practical version of that protocol, written for the clinic manager who buys the stock and for the lead who has to defend the routine during an inspection. It applies to surgical and non-surgical facial work alike, because the ambiguity does not come from the procedure. It comes from how the mask is described.
What does the barrier half of the protocol require?
The two halves are separate because a barrier mask answers who is protected from what, while an aftercare mask answers what is being put on compromised skin. Three decisions, made once and reviewed annually, cover the barrier side: who wears a mask, at which steps, and to what performance level. The "who" is not only the clinician: in a room with a facial wound open, everyone in it is inside the splash zone.
The "which steps" question is usually answered by the shape of the visit. Screening at the door, marking and photography, the procedure itself, the aftercare mask, discharge instructions. A mask worn through all five is comfortable for nobody and will be removed under the nose by the fourth step, which is worse than not requiring it at the first. Most clinics land on: required for staff during the procedure and the aftercare step, required for the patient whenever a staff member is within two metres, and dropped for the solo photography step.
The third decision, performance level, is where a buyer needs the standard in front of them rather than a brand promise. CliniEco's ASTM Level 2 face masks sit in the middle of the range for a reason: they cover droplet and light splash exposure, which is what a post-operative dressing change actually produces.
Which barrier mask level does each step in the clinic need?
Work from the task, not from the room. The table below maps the steps in a facial procedure visit to a barrier level and names what drives the choice.
| Step in the visit | Barrier for staff | Driven by | Watch item |
|---|---|---|---|
| Screening and intake | Procedure mask acceptable | Distance, no splash | Mask stored in a pocket between patients |
| Marking and photography | None required if staff stay behind the patient | No fluid exposure | Staff pulling mask down rather than off |
| Procedure with open field | Surgical mask, fluid resistant | Splash and spray from the field | Mask worn below the nose after hour two |
| Aftercare mask application | Surgical mask, fluid resistant | Close contact, wet product | Gloves and mask both removed at the wrong moment |
| Aerosol-generating step | Respirator approved to 42 CFR Part 84 | Aerosol, airborne precaution | No fit check done before the first task |

Two rows in that table are where the arguments happen. The first is the aerosol row: a clinic that uses a laser plume device is doing an aerosol-generating step, and the mask for that step is a respirator, not a surgical mask with a higher number printed on the box. The second is the marking row, where a mask that is dropped and re-donned between patients collects the exact contamination the protocol exists to prevent.
For the labelling side, section 21 of the Medical Devices Regulations sets out what a mask label in Canada has to carry, including the manufacturer's name and address, the device identifier, the expiry date where one exists, and the purposes and uses for which the device is sold. That last item is the one an inspector reads first, because it defines the use the clinic is entitled to make of the product.
What changed in ASTM F2100 in 2026?
Enough that a specification quoted from memory is now wrong. The 2025 edition was a materials specification: bacterial filtration efficiency, differential pressure, sub-micron particulate filtration efficiency, resistance to penetration by synthetic blood, flammability. Testing on material, in other words.
ASTM F2100-26, listed as active and last updated in March 2026, is titled Standard Specification for Medical Face Masks and does more than measure fabric. It sets minimum requirements for design, including the area of coverage over nose and mouth and the retention system; for performance classification; for labelling of the packaging; for user instructions that guide selection between classifications and describe when to replace and how to dispose; and for conformity assessment through a Supplier Declaration of Conformity following Guide F3050, Annex A3, Model B.
Two exclusions in the same document matter to a clinic. It addresses single-use disposable masks only, and it does not address fit, meaning inward or outward leakage at the mask edge is outside its scope. A buyer who reads "F2100 compliant" as evidence of fit has read it wrong. Fit is a separate exercise, and the enforcement route in the United States for the respirator version runs through 42 CFR Part 84 and NIOSH approval, not through the mask standard.
When does the aftercare mask stop being a cosmetic?
When the words on the label or in the clinic's script give it a job that only a drug can do. This is the dividing line, and it is a paperwork line rather than a formulation line.

In the United States, 21 U.S.C. 321(g)(1) defines a drug as an article intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease, or intended to affect the structure or function of the body. Section 321(i) defines a cosmetic by what it is for: cleansing, beautifying, promoting attractiveness, altering the appearance. A hydrating sheet mask sits in the second definition. Change the claim to wound repair, barrier restoration after a burn, or prevention of post-procedure infection, and the same sheet becomes a drug, which means the cosmetic filings do not apply to it at all.
Canada uses the same logic through the definitions in the Food and Drugs Act and the Cosmetic Regulations. Section 16 of the Act prohibits selling a cosmetic that contains a substance that may cause injury when used as directed or as customarily used, and the Cosmetic Ingredient Hotlist is the administrative document that tells a formulator which substances are prohibited outright and which are permitted only under a concentration limit or cautionary statement. The Hotlist is explicitly not exhaustive, and Health Canada can enforce against a substance that is not on it.
That asymmetry is worth writing into the protocol. A clinic that sources an aftercare mask from a supplier who cannot produce an ingredient list has no way to check the one document that decides whether the product may be sold in Canada.
How do MoCRA filings differ from Health Canada cosmetic notification?
By timing, by unit and by what gets filed. The table compares the obligations a supplier meets in each country for the same aftercare mask.
| Obligation | Canada | United States (MoCRA) |
|---|---|---|
| Filing trigger | Within 10 days after first sale | Facility registration and product listing, both filed before or at market entry |
| Unit filed | The cosmetic product, with ingredient concentrations | Each facility, plus each product listing |
| Renewal | No periodic renewal; notify changes | Facility registration renews every two years; listing updates annually |
| Adverse events | No cosmetic-specific federal clock | Serious adverse event reported within 15 business days, with a copy of the retail label |
| Records | Not specified for cosmetics | Six years per adverse event report, three years for a small business |
| Pre-market step | None | None, except colour additives |
The 15-business-day adverse event clock reaches into a clinic's own paperwork. The report must carry a copy of the label as it appears in or on the retail package, and a clinic that never records which lot went on which patient cannot help its supplier meet that clock.
The small business exemption is narrower than it looks. Under 21 U.S.C. 364h the exemption from the registration and listing requirements is available to a responsible person whose average gross annual sales of cosmetic products in the United States over the previous three years is below one million dollars, and it is not available at all for products that regularly contact the mucous membrane of the eye, are injected, are intended for internal use, or are intended to alter appearance for more than 24 hours where removal by the consumer is not part of the customary use.

What belongs on the treatment record?
Four fields for the mask step, and they take fifteen seconds. Product name as it appears on the package. Lot number copied from the sachet, not from the carton. Time applied and time removed. The initials of the person who applied it.
Two more fields belong with them if the visit involved an open field: which barrier level the clinician wore, and whether a fit check was done where a respirator was used. In the United States, OSHA 1910.1030 requires a written exposure control plan and makes the employer responsible for the PPE decisions in it, so the record is the evidence that the plan was followed rather than just published.
A clinic running 30 procedures a week generates about 1,560 records a year. Stored as a single sheet per day with five columns, that is a binder. Stored as a line in the practice software, it is a filter that answers a supplier's traceability request in a minute.
How many masks does the protocol consume per 100 procedures?
Do the arithmetic in two lanes. Barrier masks follow staff-hours, not patient count: a two-clinician room doing 100 procedures with about 45 masked minutes each consumes roughly 150 staff masks once the halfway change is counted.
Aftercare masks follow the patient count exactly: one per procedure, plus a small allowance for a mask that is opened and rejected. On 100 procedures that is roughly 105 units, and the same number tells the buyer whether to order in single-patient packs for a trial or in a professional case for the month.
The third lane is the one that gets forgotten: a second mask for patients re-dressed on day two or three. A protocol that does not state that number gets interpreted differently in each room.
What goes wrong most often?
Four failures account for most of the friction, and each has a supply-side fix. A barrier mask hung on a hook for the next patient turns a single-use item into a shared one: put a box at each station. An aftercare mask applied by a clinician whose glove just held a phone needs a written sequence and a tray that holds the sachet instead of a palm.
The third is documentation drift, where the lot is written on day one and not on day two: the fix is a lot field printed on the daily sheet. The fourth is a supplier change made on price alone, with no check that the new mask's label names the same intended use and the same performance classification as the one it replaced.
Clinics that run masking inside a wider aftercare routine order both sides from one account so labels and lot records stay consistent. A medical aesthetics supply page groups the treatment-room consumables in one place. Facilities buying for several rooms or several sites usually work through a clinic and volume account, where case quantities and purchase-order billing are handled per site, and the B2B wholesale collection lists the lines stocked for institutional buyers. Reselling? become a distributor.
References
- 21 CFR 878.4040, Surgical apparel (classification of surgical gowns and masks) (checked 10 November 2026)
- ASTM F2100-26, Standard Specification for Medical Face Masks (checked 10 November 2026)
- 42 CFR Part 84, Approval of Respiratory Protective Devices (NIOSH) (checked 10 November 2026)
- 21 U.S.C. 321, Definitions of drug, device and cosmetic, Federal Food, Drug, and Cosmetic Act (checked 10 November 2026)
- 21 U.S.C. 364a, Adverse events, Modernization of Cosmetics Regulation Act (checked 10 November 2026)
- 21 U.S.C. 364c, Registration and product listing, Modernization of Cosmetics Regulation Act (checked 10 November 2026)
- 21 U.S.C. 364e, Labeling, Modernization of Cosmetics Regulation Act (checked 10 November 2026)
- 21 U.S.C. 364h, Small businesses, Modernization of Cosmetics Regulation Act (checked 10 November 2026)
- 21 U.S.C. 379e, Listing and certification of color additives (checked 10 November 2026)
- 21 CFR 701.3, Designation of ingredients on cosmetic labels (checked 10 November 2026)
- Cosmetic Regulations (C.R.C., c. 869), Canada, consolidated text (checked 10 November 2026)
- Cosmetic Regulations, section 30, notification to the Minister after first sale (checked 10 November 2026)
- Food and Drugs Act (R.S.C., 1985, c. F-27), section 16, prohibited sales of cosmetics (checked 10 November 2026)
- Health Canada, Cosmetic Ingredient Hotlist, prohibited and restricted ingredients (checked 10 November 2026)
- Medical Devices Regulations (SOR/98-282), section 21, label content (checked 10 November 2026)
- ISO 15223-1:2021, Symbols to be used with information supplied by the manufacturer (checked 10 November 2026)
- ISO 13485:2016, Medical devices, quality management systems (checked 10 November 2026)
- OSHA 1910.1030, Bloodborne Pathogens (checked 10 November 2026)
Printable companion: the free treatment-room log sheets carry a lot field and a time-on, time-off line for the aftercare mask, so the day is written as it happens rather than rebuilt from memory.
Turning a procedure count into an order? The clinic supply planner converts procedures per week into masks and barrier masks per quarter.
Related Reading
- Which cooling and soothing supplies do Canadian aesthetic clinics reorder monthly?
- What does a US aesthetic clinic ask a mask supplier before switching vendors?
- Post-Procedure Repair Masks for Aesthetic Clinics in Canada: Case Counts and Reorder Points
Frequently Asked Questions
What is a post-operative mask protocol in a plastic surgery clinic?
It is the written set of rules for two products that are used minutes apart. The first is the barrier mask worn by staff and, where the clinic requires it, by the patient. The second is the aftercare mask applied to treated skin before the patient leaves. Each half answers to a different regulator, which is why a single document has to carry two sets of requirements.
Is a post-procedure sheet mask a cosmetic or a drug in the US?
A cosmetic, unless the label or the clinic's own claim gives the mask a therapeutic purpose. Under 21 U.S.C. 321(g)(1) an article intended to affect the structure or function of the body, or to mitigate or prevent disease, is a drug. Hydrating and beautifying language keeps it a cosmetic. Any claim that the mask repairs a wound or prevents infection moves the product into drug territory.
Does MoCRA require pre-market approval for a sheet mask?
No. MoCRA adds facility registration and product listing, not a pre-market clearance. The narrow exception that survives is colour additives, which must be listed and, where the regulation requires it, batch certified under 21 U.S.C. 379e. A sheet mask that contains no colour additive has no pre-market step in the United States.
How long does a clinic have to notify Health Canada about a new cosmetic?
Ten days after the manufacturer or importer first sells it, under section 30(1) of the Cosmetic Regulations. The notification carries the ingredient list by INCI name with either an exact concentration or one of the concentration bands set out in the table to that section. It is a post-market filing, not an approval.
Which ASTM F2100 edition applies to masks bought in 2026?
ASTM F2100-26, listed by ASTM as active and last updated in March 2026. The edition changed the document from a materials specification into a full product specification covering design, labelling, user instructions, classification and conformity assessment, and it states that it addresses single-use disposable masks only.
Do staff need an N95 for post-operative visits?
Not for a routine dressing check on a patient who screens negative for respiratory symptoms. A surgical mask is the barrier for splash and droplet exposure in that setting. A respirator becomes the requirement when the clinic is doing an aerosol-generating step or when an airborne precaution is in force, and in the United States the respirator itself must be approved under 42 CFR Part 84.
What has to be written in the treatment record for the mask step?
Four things: which product was applied, its lot number, the time it went on and came off, and who applied it. If a patient reports a reaction later, those four fields are what let the clinic trace the batch and answer a regulator or a manufacturer within the reporting window.
Can a Canadian clinic use a US supplier's MoCRA paperwork as evidence of compliance?
No. Facility registration and product listing are US filings for a US market. What a Canadian buyer needs instead is the Canadian seller's name and address on the inner label, the cosmetic notification having been filed, and the ingredient list checked against the Cosmetic Ingredient Hotlist.
Last updated: November 2026. CliniEco Medical is a licensed medical device establishment (MDEL #35334).